DIGITOXIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for digitoxin and what is the scope of patent protection?
Digitoxin
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for DIGITOXIN
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 2 |
Patent Applications: | 6,596 |
DailyMed Link: | DIGITOXIN at DailyMed |
Recent Clinical Trials for DIGITOXIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Texas Southwestern Medical Center | Phase 1 |
Pamela L. Zeitlin, MD, PhD | Phase 2 |
National Jewish Health | Phase 2 |
Medical Subject Heading (MeSH) Categories for DIGITOXIN
Anatomical Therapeutic Chemical (ATC) Classes for DIGITOXIN
US Patents and Regulatory Information for DIGITOXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | CRYSTODIGIN | digitoxin | INJECTABLE;INJECTION | 084100-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |